News
SOPH
5.89
+2.43%
0.14
Weekly Report: what happened at SOPH last week (0622-0626)?
Weekly Report · 5h ago
SOPHiA GENETICS Raises $57.5 Million in June 2026 Share Offering
TipRanks · 06/22 14:34
SOPHiA GENETICS Shareholders Back 2025 Results, Board Line-Up and Capital Changes at June 18 AGM
TipRanks · 06/22 12:26
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting
PR Newswire · 06/22 12:25
Weekly Report: what happened at SOPH last week (0615-0619)?
Weekly Report · 06/22 09:15
SOPHiA Genetics Closes Public Offering Of $57 Mln Of Shares
NASDAQ · 06/22 06:57
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares
PR Newswire · 06/19 12:00
SOPHiA Genetics: Strong Growth Meets A Critical Execution Phase
Seeking Alpha · 06/18 12:22
Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga · 06/17 12:03
SOPHiA Announces Pricing Of $50 Mln Public Offering At $4.75 Per Share
NASDAQ · 06/17 11:01
Stock Market Today: Dow Jones Futures Tumble, S&P 500 Gains As Investors Await FOMC Decision—Amkor, La-Z-Boy In Focus
Benzinga · 06/17 09:29
Biggest stock movers Wednesday: LZB, SPCX, and more
Seeking Alpha · 06/17 09:01
CarMax, Jabil And 3 Stocks To Watch Heading Into Wednesday
Benzinga · 06/17 06:50
SOPHiA GENETICS prices $50M public offering at $4.75 per share
Seeking Alpha · 06/17 05:15
Sophia Genetics 10.5M share Spot Secondary priced at $4.75
TipRanks · 06/17 02:50
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares
PR Newswire · 06/17 01:21
Sophia Genetics $40M Spot Secondary re-offered at $4.75
TipRanks · 06/16 21:45
Stocks to watch on Tuesday after hours: LZB, AMCX, SOPH
Seeking Alpha · 06/16 20:36
Sophia Genetics announces ordinary share offering, no amount given
TipRanks · 06/16 20:26
SOPHiA GENETICS files for proposed underwritten public offering
Seeking Alpha · 06/16 20:25
More
Webull provides a variety of real-time SOPH stock news. You can receive the latest news about Sophia Genetics Sa through multiple platforms. This information may help you make smarter investment decisions.
About SOPH
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.